← Leaderboards
Rebekah Dadey
University Of Pittsburgh At Pittsburgh
$90,536
Attributed
$90,536
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $45.5K · FY2019–20$50K$37.5K$25K$12.5K$0
'19
'20
Funding mix
By agency
NIH$90,536 · 1
By mechanism
F31$90,536 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Pittsburgh At Pittsburgh
Same institution · by research overlap
- Dario Aa Vignali$40,087,127
- Hassane M Zarour$16,372,397
- Jeremy Scott Tilstra$925,196
- Heth R. Turnquist$7,881,591
- Lynn A Worobey$1,292,756
Others in their field
Other Emerging Leaders on “Anti-Pd-1”
- John Freymann · Leidos Biomedical Research, Inc.$5,261,900
- Tina Garyantes · Linnaeus Therapeutics, Llc$5,000,000
- Amaia Lujambio · Icahn School Of Medicine At Mount Sinai$4,251,878
- Alexander Huang · University Of Pennsylvania$3,639,634
- Yuliya Pylayeva-Gupta · Univ Of North Carolina Chapel Hill$3,602,417
- Jun Wang · New York University School Of Medicine$3,408,076
Research focus
Anti-Pd-1Anti-Pd1 TherapyAntitumor ResponseAutoimmune ProcessAutoimmunityBindingCd8-Positive T-LymphocytesCellsCell Surface ProteinsChip-SeqCoinColon AdenocarcinomaCtla4 GeneDna MethylationDna Modification MethylasesDnmt3aDnmt3b GeneEnzymesEventExperimental StudyFlow CytometryFoxp3 GeneGenetic Enhancer ElementAftercare